Figure 4 Viral dynamics and infected cells (tissue damage) under TDF-like antiviral treatment without innate immunity. A-C treatment with TDF-like antiviral starting 48h before expected peak viral load and D-F starting 24h before expected peak viral load. Grey represents infection without antivirals, purple infection under moderately effective antiviral (60% inhibition) and green highly effective antiviral (90% inhibition).